Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: A Study to Evaluate the Safety of Empliciti® (Elotuzumab) When Treating Patients With Multiple Myeloma in Taiwan
A safety study of Empliciti (elotuzumab) in patients with multiple myeloma in Taiwan has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: ST-067 and Teclistamab for the Treatment of Relapsed or Refractory Multiple Myeloma [Phase 1]
A Phase 1 clinical trial evaluating ST-067 in combination with Teclistamab for relapsed or refractory multiple myeloma has been terminated. …
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: Check Point Inhibition After Autologous Stem Cell Transplantation in Patients at High Risk of Post Transplant Recurrence [Phase 1, Phase 2]
A Phase 1/2 trial of checkpoint inhibition after autologous stem cell transplantation for patients at high risk of post-transplant recurrenc…
-
CLINICAL_TRIALS trial_result · 2025-07-24Clinical Trial Update: Cyclosporine in Combination With Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma Refractory to Carfilzomib and High Expression of PPIA Gene in Myeloma Cells [Phase 1]
Phase 1 trial evaluating cyclosporine in combination with carfilzomib and dexamethasone in patients with relapsed or refractory multiple mye…
-
CLINICAL_TRIALS trial_result · 2025-07-24Clinical Trial Update: BCMA-targeted LCAR-BCDR Cells in Patients With Relapsed/Refractory Multiple Myeloma [Phase 1]
A Phase 1 clinical trial evaluating BCMA-targeted LCAR-BCDR Cells in patients with relapsed/refractory multiple myeloma has been terminated …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-24Clinical Trial Update: Noninvasive Detection and Assessment of Therapy Response in Multiple Myeloma Using Whole-Body MRI [NA]
A clinical trial evaluating noninvasive whole-body MRI to detect and monitor therapy response in multiple myeloma has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-07-24Clinical Trial Update: Ixazomib-pomalidomide-dexamethasone as Second or Third-line Combination Treatment for Patients With Relapsed and Refractory Multiple Myeloma Previously Treated With Daratumumab, Lenalidomide and Bortezomib [Phase 2]
Phase 2 trial evaluating ixazomib-pomalidomide-dexamethasone as second or third-line treatment for relapsed and refractory multiple myeloma …
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: Prospective Comparison of 18F-choline PET/CT and 18F-FDG PET/CT in the Initial Work-up of Multiple Myeloma [Phase 3]
A Phase 3 prospective comparison of 18F-choline PET/CT versus 18F-FDG PET/CT for the initial work-up of multiple myeloma. The trial status i…
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: A Phase I Clinical Trial of Y150 in the Treatment of Relapsed or Refractory Multiple Myeloma [Phase 1]
This document reports the completion of a Phase I clinical trial of Y150 in relapsed or refractory multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: Multiple Myeloma Yoga Pilot Study [NA]
A pilot study evaluating yoga for individuals with multiple myeloma has completed, sponsored by the University of Arizona.
-
CLINICAL_TRIALS trial_result · 2025-07-14Clinical Trial Update: A Study Evaluating Safety, Tolerability, and Clinical Activity of Forimtamig-Based Treatment Combinations in Participants With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]
Completed Phase 1/2 trial evaluating safety, tolerability, and preliminary clinical activity of Forimtamig-based treatment combinations in r…
-
CLINICAL_TRIALS trial_result · 2025-07-09Clinical Trial Update: AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]
Phase 1 first-in-human study of AMG 176 in relapsed or refractory multiple myeloma and acute myeloid leukemia was terminated with results po…
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: Isa-RVD Study in Patients With Newly Diagnosed Multiple Myeloma [Phase 2]
A Phase 2 trial evaluating Isa-RVD (isatuximab plus lenalidomide, bortezomib, and dexamethasone) for newly diagnosed multiple myeloma, with …
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: Phase II Clinical Study on the Safety and Efficacy of Combined CAR-T Therapy Following Autologous Stem Cell Transplantation in Multiple Myeloma [NA]
This clinical trial update describes a Phase II study investigating the safety and efficacy of a combined CAR-T cell therapy after autologou…
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: A Study to Compare the Effects of Elranatamab (PF 06863135) Versus Standard of Care (SOC) in Patients With Multiple Myeloma (MM) in Germany and US
A completed study comparing Elranatamab (PF-06863135) to standard-of-care therapy in multiple myeloma patients in Germany and the United Sta…
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: Ixazomib and Dexamethasone Versus Ixazomib, Dexamethasone and Lenalidomide, Randomized With NFKB2 Rearrangement [Phase 2]
Phase 2 randomized trial comparing ixazomib and dexamethasone with and without lenalidomide in relapsed/refractory multiple myeloma; results…
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: CART-38 in Adult AML and MM Patients [Phase 1]
Phase 1 study of CART-38 in adults with acute myeloid leukemia and multiple myeloma has been terminated; this update notes the status of the…
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: CART-BCMA Cells for Multiple Myeloma [Phase 1]
Phase 1 trial of CART-BCMA CAR-T cells for multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: Kidney Therapy for Free Light Chain Removal in Patients With Multiple Myeloma & Cast Nephropathy
Clinical trial update indicates completion of a kidney therapy approach to remove free light chains in patients with multiple myeloma and ca…
-
CLINICAL_TRIALS trial_result · 2025-06-24Clinical Trial Update: Dexamethasone, Elotuzumab, and Pomalidomide in Treating Patients With Refractory Multiple Myeloma [Phase 2]
Phase 2 study of dexamethasone, elotuzumab, and pomalidomide in patients with refractory multiple myeloma; the trial has completed and resul…
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Lenalidomide in Multiple Myeloma (MM) [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating continuous subcutaneous lenalidomide in patients with multiple myeloma, focusing on safety, efficac…
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: Feasibility, Safety and Effectivity of an Exercise Intervention for Newly Diagnosed Multiple Myeloma Patients During Induction Therapy [NA]
A clinical trial update evaluating the feasibility, safety, and effectiveness of an exercise program for newly diagnosed multiple myeloma pa…
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: A Comparative Clinical Study to Determine the Optimal Initial Therapy for Multiple Myeloma
This document reports the results of a completed comparative clinical trial intended to determine the optimal initial therapy for multiple m…
-
CLINICAL_TRIALS trial_result · 2025-06-13Clinical Trial Update: Ph I Study in Adult Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]
Phase 1 clinical trial update for adults with relapsed or refractory multiple myeloma sponsored by Nerviano Medical Sciences. The study stat…
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: A Study to Investigate Safety and Efficacy With SAR445514 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) and Relapsed/Refractory Light-chain Amyloidosis (RRLCA) [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating SAR445514 in relapsed/refractory multiple myeloma and light-chain amyloidosis has been terminated.